Sebastian Ochsenreither

Author

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Ochsenreither, Sebastian, S Ochsenreither, S. Ochsenreither, SEBASTIAN OCHSENREITHER, Sebastian OCHSENREITHER, Sebastian Ochsenreither, Sebastian Ochsenreither,

222

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Heidelberg University Humboldt-Universität zu Berlin Freie Universität Berlin University Hospital Heidelberg

About

Sebastian Ochsenreither is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	27	1.3K
2	Health Sciences	6	6	315
3	Cell Biology	4	4	193
4	Diagnostic Sciences	2	2	57
5	Hepatology	2	2	57

Sebastian Ochsenreither

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma Paul Nathan, Jessica C. Hassel, Piotr Rutkowski, New England Journal of Medicine	2021	806
Transferred WT1-Reactive CD8 <sup>+</sup> T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients Aude G. Chapuis, Gunnar B. Ragnarsson, Hieu Nguyen, Science Translational Medicine	2013	306
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial Denis Soulières, Sandrine Faivre, Éva Remenár, The Lancet Oncology Placebo-controlled Phase 2Neoadjuvant TherapyMedicinePathologyPlatinum-pretreated Recurrent	2017	214
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial J. Guigay, Anne Aupérin, Jérôme Fayette, The Lancet Oncology Gortec 2014-01 TpextremeNeoadjuvant TherapyMedicineCisplatin Versus PlatinumHead And Neck Cancer	2021	214
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma Jessica C. Hassel, Sophie Piperno‐Neumann, Piotr Rutkowski, New England Journal of Medicine	2023	213
Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis Katrin Kuhls, Lyvia Keilonat, Sebastian Ochsenreither, Microbes and Infection Multilocus Microsatellite TypingMolecular EcologyParasitic ProtozoaMedicineGenetics	2007	170
Multilocus Microsatellite Typing as a New Tool for Discrimination of <i>Leishmania infantum</i> MON-1 Strains Sebastian Ochsenreither, Katrin Kuhls, Matthias Schaar, Journal of Clinical Microbiology	2006	110
Differentiation and Gene Flow among European Populations of Leishmania infantum MON-1 Katrin Kuhls, Carmen Chicharro, Carmen Cañavate, PLoS neglected tropical diseases	2008	96
Expression of the Stem Cell Markers Nestin and CD133 on Circulating Melanoma Cells Alberto Fusi, Uta Reichelt, Antonia Busse, Journal of Investigative Dermatology Lineage PlasticityMedicineStem CellsImmunologyMelanoma	2010	74
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.) Stephan Kreher, Sebastian Ochsenreither, Ralf Ulrich Trappe, Annals of Hematology Hematological MalignancyThrombosisVenous ThrombosisGerman SocietyMedicine	2014	68

Page 1